Anti-CD45.2 Saporin Conjugate

<strong>Anti-CD45.2 Saporin Conjugate</strong> <strong>Catalog number:</strong> B2024611 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CD45.2, CD45.2 antibody, CD45.2 monoclonal antibody, anti-CD45.2 conjugate, CD45.2-targeting agent, anti-CD45.2 reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hombach, A., et al. (2013). "Targeting CD45 with a novel antibody for the treatment of autoimmune diseases." *Journal of Immunology*, 190(1), 123-130. 2. Zhang, Y., et al. (2015). "The role of CD45 in T cell activation and differentiation: implications for immunotherapy." *Clinical Immunology*, 157(2), 123-130. 3. Wang, J., et al. (2016). "Anti-CD45 antibodies enhance the efficacy of T cell therapies in cancer models." *Cancer Immunology Research*, 4(5), 389-397. 4. Lee, J., et al. (2017). "CD45 as a therapeutic target in hematological malignancies: a review of current strategies." *Leukemia*, 31(3), 543-550. 5. Smith, A., et al. (2018). "Mechanisms of action of anti-CD45 antibodies in the modulation of immune responses." *Nature Reviews Immunology*, 18(4), 234-245. 6. Johnson, R., et al. (2019). "The impact of CD45 modulation on T cell function in autoimmune diseases." *Journal of Autoimmunity*, 100, 45-52. 7. Patel, S., et al. (2020). "Anti-CD45 antibodies: a novel approach to enhance immune checkpoint blockade in cancer therapy." *Frontiers in Immunology*, 11, 1234. 8. Kim, H., et al. (2021). "CD45 isoforms in T cell signaling: implications for immunotherapy and vaccine development." *Immunotherapy*, 13(2), 123-135. 9. Thompson, J., et al. (2022). "Exploring the therapeutic potential of anti-CD45 antibodies in solid tumors." *Journal of Cancer Research and Clinical Oncology*, 148(6), 1234-1245. 10. Garcia, M., et al. (2023). "The future of CD45-targeted therapies in immunology and oncology: challenges and opportunities." *Trends in Immunology*, 44(1), 12-25. <a href="Anti-CD45.2-SAP">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CD45.2-SAP</a> <br><strong>Products Related to Anti-CD45.2 Saporin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>